The rating confirmation comes shortly after the health system, centered around the 305-bed Stamford Hospital, reported positive operating income of $4.9 million for the fiscal year ended Sept. 30. Overall net loss for the year totaled approximately $38 million.
The system’s strong market share, which includes a 76 percent share in its primary service area, will also continue to support Stamford over the next several years, as will its partnership agreements with facilities including New York City-based Hospital for Special Surgery, Fitch said.
“The rating is further supported by Stamford’s dominant market position in a good primary service area with a very strong demographic profile,” Fitch said.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
